
Sleep ‘Sweet Spot’ Keeps Brain Sharp
Too much sleep and too little sleep can contribute to cognitive decline, researchers report. Learn more.

Too much sleep and too little sleep can contribute to cognitive decline, researchers report. Learn more.

New early-onset Alzheimer’s data show that lecanemab can slow functional decline—even while tau continues to spread in the brain. The research helps explain how amyloid-lowering treatments may still preserve daily life, despite the disease’s complexity.

People with dementia who were consistently seen by the same General Practitioner (GP) are given fewer medicines and are less likely to be given medicines that can cause problems, according to researchers at University of Exeter. Learn more.

Amyloid is one of the leading culprits behind Alzheimer’s. Scientists know it damages memory by killing brain cells. Now research reveals how amyloid triggers memory loss in perfectly healthy brain cells as well. Learn more about how Alzheimer’s develops.

Getting out into the fresh air and taking a walk does good things for your brain and well-being, researchers say.

A new test that can be completed in less than three minutes enables simple, accurate detection of cognitive impairment and Alzheimer’s in cognitively normal adults, including those with no symptoms of dementia. Find out more.

Scientists say the neurons responsible for transforming experiences into memories are always the first to go in Alzheimer’s. Now they’re taking a closer look to try to figure out why, and what to do about it.

A research study finds when young healthy men had a full, uninterrupted night of rest, their blood levels showed a reduced level of tau, the biomarker for Alzheimer’s disease. The level was higher when they lost just one night of sleep. Learn more.

Higher midlife omega-3 levels were linked to lower early-onset dementia risk. It’s not proof — but it’s a meaningful signal worth paying attention to.

In a one-hour seminar, a leading neurologist answers the most important questions families ask about what these new therapies can realistically deliver — from effectiveness and safety to eligibility, infusion logistics, cost, and access.

Over 50% of people with dementia have evidence of more than one type of dementia. A South Korean trial is testing Lilly’s Alzheimer’s drug Kisunla in people with both Lewy body dementia and Alzheimer’s. Success could open a new chapter in treating mixed dementia.

Vascular dementia has struck a million Americans. It’s often caused by a stroke. Learn how easy it is to prevent a stroke when you know the signs and quickly call 911.

VIDEO + ARTICLE: The world’s lowest rates of dementia are found in Amazonian indigenous groups. Now there’s more evidence their lifestyles may hold clues to preventing Alzheimer’s. Learn more.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.



We use cookies and similar technologies to improve your experience, understand how our content is used, and support relevant advertising that helps keep Alzheimer’s Weekly free to readers. You can choose to accept, deny, or manage your preferences at any time. Declining certain cookies may affect features such as embedded videos, comments, and personalized advertising.